• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immunome Inc (NQ: IMNM )

    12.97 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 352
    Open 12.97
    Bid (Size) 12.70 (2)
    Ask (Size) 13.22 (1)
    Prev. Close 12.97
    Today's Range 12.97 - 12.97
    52wk Range 6.930 - 30.96
    Shares Outstanding 60,054,372
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Immunome to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire

    Performance

    YTD
    +17.80%
    +17.80%
    1 Month
    +4.18%
    +4.18%
    3 Month
    -1.97%
    -1.97%
    6 Month
    -15.39%
    -15.39%
    1 Year
    +47.72%
    +47.72%

    More News

    Read More
    Immunome Presents Compelling Preclinical Data Demonstrating Robust Anti-Tumor Activity for IM-1021
    From Immunome, Inc.
    Via Business Wire
    Evaluating Immunome: Insights From 4 Financial Analysts
    Via Benzinga
    Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium
    From Immunome, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Immunome Appoints Roee Shahar as Executive Vice President, Commercial
    From Immunome, Inc.
    Via Business Wire
    Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Immunome, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024
    From Immunome, Inc.
    Via Business Wire
    Immunome to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
    From Immunome, Inc.
    Via Business Wire
    Immunome Stock Sees RS Rating Jump To 91
    Via Investor's Business Daily
    IMNM Stock Earnings: Immunome Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Immunome Reports Second Quarter 2024 Financial Results and Provides Business Update
    From Immunome, Inc.
    Via Business Wire
    Immunome Provides Update on Recent Business Development Activity Expected to Expand ADC Capabilities
    From Immunome, Inc.
    Via Business Wire
    Immunome Appoints Phil Tsai as Chief Technical Officer
    From Immunome, Inc.
    Via Business Wire
    Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Immunome Announces Completion of Purchase of Assets from Atreca
    From Immunome, Inc.
    Via Business Wire
    Immunome Announces Promotion of Max Rosett to Chief Financial Officer
    From Immunome, Inc.
    Via Business Wire
    IMNM Stock Earnings: Immunome Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Immunome Reports First Quarter 2024 Financial Results and Provides Business Update
    From Immunome, Inc.
    Via Business Wire
    Immunome to Present at 2024 Bank of America Healthcare Conference
    From Immunome, Inc.
    Via Business Wire
    Immunome Appoints Kinney Horn as Chief Business Officer
    From Immunome, Inc.
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.